Dodge & Cox – NBIX history
- Issuer:
- Neurocrine Biosciences, Inc.
- Quarters tracked:
- 14 (Q4 2023 → Q1 2026)
- Current shares:
- 5,461,037
- Current value:
- $719.44M
- Peak shares:
- 5,566,814 (Q2 2025)
- Overall change:
- +334%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 5,461,037 | $719.44M | $131.74 | -47,005 | -1% |
| Q4 2025 | 5,508,042 | $781.21M | $141.83 | -48,576 | -1% |
| Q3 2025 | 5,556,618 | $780.04M | $140.38 | 0 | 0% |
| Q3 2025 | 5,556,618 | $780.04B | $140380.00 | -10,196 | 0% |
| Q2 2025 | 5,566,814 | $699.69M | $125.69 | 0 | 0% |
| Q2 2025 | 5,566,814 | $699.69B | $125690.00 | +32,190 | +1% |
| Q1 2025 | 5,534,624 | $612.13M | $110.60 | 0 | 0% |
| Q1 2025 | 5,534,624 | $612.13B | $110600.00 | +2,518,199 | +83% |
| Q4 2024 | 3,016,425 | $411.74B | $136500.00 | 0 | 0% |
| Q4 2024 | 3,016,425 | $411.74M | $136.50 | +1,728,605 | +134% |
| Q3 2024 | 1,287,820 | $148.38M | $115.22 | +7,000 | +1% |
| Q2 2024 | 1,280,820 | $176.33M | $137.67 | +15,576 | +1% |
| Q1 2024 | 1,265,244 | $174.50M | $137.92 | +5,500 | 0% |
| Q4 2023 | 1,259,744 | $165.98M | $131.76 | — | NEW |